Structure Therapeutics Inc. (GPCR) Income Statement Analysis - Revenue, Earnings & Profitability Metrics - Stocknear

Structure Therapeutics In...

NASDAQ: GPCR · Real-Time Price · USD
21.23
-0.85 (-3.85%)
At close: Sep 08, 2025, 11:32 AM

Structure Therapeutics Income Statement

Financials in USD. Fiscal year is January - December.
Fiscal Year FY 2024 FY 2023 FY 2022 FY 2021
Period Ending Dec 31, 2024 Dec 31, 2023 Dec 31, 2022 Dec 31, 2021
Revenue
n/a n/a n/a n/a
Cost of Revenue
2.6M 949.17K 623.26K 266.35K
Gross Profit
-2.6M -949.17K -623.26K -266.35K
Operating Income
-158.23M -102.78M -52.56M -37.7M
Interest Income
36.03M 13.38M 1.26M 122.00
Pretax Income
-122.22M -89.38M -51.3M -37.82M
Net Income
-122.53M -89.62M -51.32M -38.05M
Selling & General & Admin
49.41M 32.67M 16.37M 8.59K
Research & Development
108.81M 70.1M 36.19M 29.11K
Other Expenses
n/a n/a n/a 37.66M
Operating Expenses
158.23M 102.78M 52.56M 37.7M
Interest Expense
n/a 13.39M n/a 122.16K
Selling & Marketing Expenses
n/a n/a n/a n/a
Cost & Expenses
158.23M 102.78M 52.56M 37.7M
Income Tax Expense
310K 236K 17K 231K
Shares Outstanding (Basic)
52.64M 36.73M 36.59M 36.59M
Shares Outstanding (Diluted)
52.64M 36.73M 36.59M 36.59M
EPS (Basic)
-2.34 -2.43 -1.44 -1.2
EPS (Diluted)
-2.34 -2.43 -1.44 -1.2
EBITDA
-158.23M -102.46M -52.28M -37.62M
EBIT
-158.23M -102.78M -52.56M -37.75M
Depreciation & Amortization
996K 316K 277K 266.35K